Lumbar Infiltration With Steroids - Effects on Pain Reduction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01330875
First received: April 5, 2011
Last updated: September 7, 2012
Last verified: September 2012
  Purpose

Questionnaire for patients who got a lumbar infiltration in our clinic. The patients will have to answer questions concerning their pain. (The lumbar infiltration itself is not part of this study)


Condition Intervention
Low Back Pain
Other: survey

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Pain reduction [ Time Frame: week 1 and 3; month 3, 6, 12 ] [ Designated as safety issue: No ]
    on visual analog scale


Estimated Enrollment: 100
Study Start Date: December 2010
Estimated Study Completion Date: January 2015
Intervention Details:
    Other: survey
    no intervention. Only questionnaire after lumbar infiltration with steroids - effects on pain reduction
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who got a lumbar infiltration in our clinic. The patients will have to answer questions concerning their pain (the lumbar infiltration itself is not part of this study).

Criteria

Inclusion criteria:

  • Patients who got a lumbar infiltration in our clinic.

Exclusion criteria:

  • Infiltration of thoracal or cervical spine.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01330875

Contacts
Contact: Sandra Blumhardt, MD sandra.blumhardt@usz.ch

Locations
Switzerland
University Hospital Zurich, Division of Rheumatology Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Sandra Blumhardt, MD University Hospital Zurich, Division of Rheumatology
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01330875     History of Changes
Other Study ID Numbers: LINFRUZ01
Study First Received: April 5, 2011
Last Updated: September 7, 2012
Health Authority: Switzerland: KEK Zurich

ClinicalTrials.gov processed this record on March 26, 2015